These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26786119)

  • 1. MicroRNAs in CD4(+) T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for type 1 diabetes.
    Zhang Y; Feng ZP; Naselli G; Bell F; Wettenhall J; Auyeung P; Ellis JA; Ponsonby AL; Speed TP; Chong MM; Harrison LC
    J Autoimmun; 2016 Apr; 68():52-61. PubMed ID: 26786119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
    Fornari TA; Donate PB; Assis AF; Macedo C; Sakamoto-Hojo ET; Donadi EA; Passos GA
    PLoS One; 2015; 10(11):e0142688. PubMed ID: 26606254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell Activation Induces Dynamic Changes in miRNA Expression Patterns in CD4 and CD8 T-cell Subsets.
    Teteloshvili N; Smigielska-Czepiel K; Kroesen BJ; Brouwer E; Kluiver J; Boots AM; van den Berg A
    Microrna; 2015; 4(2):117-22. PubMed ID: 26290349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.
    Glisic-Milosavljevic S; Waukau J; Jailwala P; Jana S; Khoo HJ; Albertz H; Woodliff J; Koppen M; Alemzadeh R; Hagopian W; Ghosh S
    PLoS One; 2007 Jan; 2(1):e146. PubMed ID: 17206281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
    Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
    Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients.
    Hezova R; Slaby O; Faltejskova P; Mikulkova Z; Buresova I; Raja KR; Hodek J; Ovesna J; Michalek J
    Cell Immunol; 2010; 260(2):70-4. PubMed ID: 19954774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.
    Yang M; Ye L; Wang B; Gao J; Liu R; Hong J; Wang W; Gu W; Ning G
    J Diabetes; 2015 Mar; 7(2):158-65. PubMed ID: 24796653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Associated Differences in MiRNA Signatures Are Restricted to CD45RO Negative T Cells and Are Associated with Changes in the Cellular Composition, Activation and Cellular Ageing.
    Teteloshvili N; Kluiver J; van der Geest KS; van der Lei RJ; Jellema P; Pawelec G; Brouwer E; Kroesen BJ; Boots AM; van den Berg A
    PLoS One; 2015; 10(9):e0137556. PubMed ID: 26360056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
    Schneider A; Rieck M; Sanda S; Pihoker C; Greenbaum C; Buckner JH
    J Immunol; 2008 Nov; 181(10):7350-5. PubMed ID: 18981158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of miR-146a and miR-142-3p as Potential Markers of Freshly Isolated or In Vitro-Expanded Human Treg cells.
    Holmstrøm K; Pedersen AE; Gad M
    Scand J Immunol; 2017 Feb; 85(2):113-121. PubMed ID: 27943367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
    Bollyky JB; Long SA; Fitch M; Bollyky PL; Rieck M; Rogers R; Samuels PL; Sanda S; Buckner JH; Hellerstein MK; Greenbaum CJ
    Clin Exp Immunol; 2013 Jun; 172(3):363-74. PubMed ID: 23600824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.
    Salas-Pérez F; Codner E; Valencia E; Pizarro C; Carrasco E; Pérez-Bravo F
    Immunobiology; 2013 May; 218(5):733-7. PubMed ID: 22999472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression.
    Stahl HF; Fauti T; Ullrich N; Bopp T; Kubach J; Rust W; Labhart P; Alexiadis V; Becker C; Hafner M; Weith A; Lenter MC; Jonuleit H; Schmitt E; Mennerich D
    PLoS One; 2009 Sep; 4(9):e7158. PubMed ID: 19777054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
    Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
    Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts.
    Zhou H; Zhao H; Hao Y; Song C; Han J; Zhang J; Gao G; Han N; Yang D; Li Y; Zhang F; Zeng H
    AIDS; 2013 Apr; 27(7):1059-69. PubMed ID: 23299175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
    Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
    J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.
    Pop SM; Wong CP; Culton DA; Clarke SH; Tisch R
    J Exp Med; 2005 Apr; 201(8):1333-46. PubMed ID: 15837817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
    Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
    BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
    Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
    J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.